Dan Teleman

No open positions remaining

Net worth: 113 268 $ as of 29/09/2026

Health Technology

Consumer Services

Government

Profile

Dan Teleman was the founder of PRF Technologies Ltd., founded in 2007, and served as Chief Executive Officer from 2007 to 2010.
Former jobs include Chief Executive Officer at Atox Bio Ltd. from 2011 to 2022, Chief Executive Officer at Pharma Two B Ltd. from 2023 to 2025, Chief Executive Officer & Director at Nasus Pharma Ltd. from 2025 to 2026, Chairman at Tamarix Pharma Ltd from 2021 to 2023, Head-Marketing & Sales at Amgen, Inc., Senior Business Development Officer at W World Corp., Principal at Israel Defense Forces, and Executive Partner at Israel Biotech Fund from 2022 to 2023.
Education includes graduate studies at Ben-Gurion University of the Negev and an MBA from The Fuqua School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NASUS PHARMA LTD. 0.26%	16/06/2026	30,696 ( 0.26% )	113 268 $	29/09/2026

Former positions of Dan Teleman

Companies	Position	End
NASUS PHARMA LTD.	Chief Executive Officer	21/07/2026
Pharma Two B Ltd. Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders	Chief Executive Officer	31/12/2024
Israel Biotech Fund Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements.	Private Equity Investor	30/04/2023
Tamarix Pharma Ltd Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis	Chairman	30/04/2023
Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections	Chief Executive Officer	30/04/2022

See the detail of Dan Teleman's experience

Education of Dan Teleman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dan Teleman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
W World Corp. W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products	Health Technology
Ben-Gurion University of the Negev Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Israel Defense Forces Israel Defense Forces SovereignGovernment National security	Government
PainReform Ltd. PainReform Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals for pain treatment	Health Technology
Atox Bio Ltd. Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections	Health Technology
Pharma Two B Ltd. Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders	Health Technology
The Fuqua School of Business The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Israel Biotech Fund Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements.	Finance
Nasus Pharma Ltd. Nasus Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops powder-based intranasal products	Health Technology
Tamarix Pharma Ltd Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis	Health Technology